Small for gestational age preterm infants: nutritional strategies and quality of growth after discharge

Paola Roggero1, Maria Lorella Giannì, Nadia Liotto

  • 1Neonatal Intensive Care Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Department of Maternal and Pediatric Sciences, University of Milan, Italy. paola.roggero@mangiagalli.it

Insights

Enriched formula did not improve catch-up growth in small for gestational age (SGA) preterm infants. While ponderal and linear growth remained unaffected, fat-free mass accretion increased, suggesting a shift in body composition.

Area of Science:

  • Neonatology
  • Pediatric Nutrition
  • Growth and Development

Background:

  • Infants born preterm, particularly those small for gestational age (SGA), face significant risks of poor postnatal growth.
  • Both SGA and appropriate for gestational age (AGA) preterm infants often exhibit persistent growth failure after hospital discharge.
  • Nutritional management post-discharge is crucial but often insufficiently addressed for these vulnerable infants.

Purpose of the Study:

  • To evaluate the impact of an enriched post-discharge formula on growth patterns in SGA preterm infants.
  • To determine if nutritional supplementation can promote catch-up growth in SGA preterm infants after hospital discharge.

Main Methods:

  • A randomized controlled trial was conducted with SGA preterm infants.
  • Infants received either an enriched post-discharge formula or a standard formula.
  • Growth parameters including ponderal, linear growth, and body composition were assessed.

Main Results:

  • The enriched formula did not significantly alter ponderal or linear growth, failing to induce early catch-up growth.
  • A notable change in growth quality was observed: fat mass accretion decelerated post-term.
  • Concurrently, there was an increase in fat-free mass accretion in infants receiving the enriched formula.

Conclusions:

  • Enriched post-discharge formula does not enhance catch-up growth in SGA preterm infants.
  • The intervention influenced body composition, shifting accretion towards fat-free mass.
  • Further research with longer follow-up and personalized nutrition strategies is recommended.

Related Concept Videos

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...